Changes in Phospholipid Composition within the Dystrophic Muscle by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Mass Spectrometry Imaging
Restricted accessResearch articleFirst published online October, 2004
Changes in Phospholipid Composition within the Dystrophic Muscle by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Mass Spectrometry Imaging
Duchenne muscular dystrophy (DMD) is a neuromuscular disease linked to the lack of dystrophin, a submembrane protein, leading to muscle weakness and associated with a defect of the lipid metabolism. A study of the fatty acid composition of glycerophos-phatidylcholines by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF-MS) and tandem mass spectrometry (MS/MS) enabled us to characterize a change in the lipid composition of dystrophic cells at the time of the differentiation. This modification has been used as a marker to identify with profiling and imaging MALDI-ToF MS regenerating areas in sections of an mdx mouse leg muscle. It is the first time that such a slight change in fatty acid composition has been observed directly on tissue slices using mass spectrometry. This approach will be useful in monitoring the treatment of muscular regeneration.
BlakeD.J.WeirA.NeweyS.E. and DaviesK.E., “Function and genetics of dystrophin and dystrophin-related proteins in muscle”, Physiol. Rev.82, 291 (2002).
2.
BulfieldG.SillerW.G.WightandP.A. and MooreK.J., “X chromosome-linked muscular dystrophy (mdx) in the mouse”, Proc. Natl. Acad. Sci. USA81, 1189 (1984).
3.
GilletB.DoanB.T.Verre-SerrieC.BarbereB.BerengerG.MorinS.KoenigJ.PeresM.SebilleA. and BeloeilJ.C., “In vivo 2D 1H NMR of mdx mouse muscle and myoblast cells during fusion: Evidence for a characteristic signal of long chain fatty acids”, Neuromuscul. Disord.3, 433 (1993).
4.
GriffinJ.L.WilliamsH.J.SangE. and NicholsonJ.K., “Abnormal lipid profile of dystrophic cardiac tissue as demonstrated by one- and two-dimensional magic-angle spinning (1)H NMR spectroscopy,”Magn. Reson. Med.46, 249 (2001).
5.
MomoseM.IguchiN.ImamuraK.UsuiH.UedaT.MiyamotoK. and InabaS., “Depressed myocardial fatty acid metabolism in patients with muscular dystrophy”, Neuromuscul. Disord.11, 464 (2001).
6.
CarrollJ.E.NorrisB.J. and BrookeM.H., “Defective [U-14 C] palmitic acid oxidation in Duchenne muscular dystrophy”, Neurology35, 96 (1985).
7.
IonasescuV.MonacoL.SandraA.IonasescuR.BurmeisterL.DeprosseC. and SternL.Z., “Alterations in lipid incorporation in Duchenne muscular dystrophy. Studies of fresh and cultured muscle”, J. Neurol. Sci.50, 249 (1981).
8.
KarasM.BachmannD.BahrU. and HillenkampF., “Matrixassisted ultra-violet laser desorption of non-volatile compounds”, Int. J. Mass. Spectrom. Ion Processes78, 53 (1987).
9.
HarveyD.J., “Matrix-assisted laser desorption/ionization mass spectrometry of phospholipids”, J. Mass Spectrom.30, 1333 (1995).
10.
CaprioliR.M.FarmerT.B. and GileJ., “Molecular imaging of biological samples: Localization of peptides and proteins using MALDI-ToF MS”, Anal. Chem.69, 4751 (1997).
11.
ChaurandP.StoeckliM. and CaprioliR.M., “Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry”, Anal. Chem.71, 5263 (1999).
12.
LiberonaJ.L.PowellJ.A.ShenoiS.PetherbridgeL.CaviedesR. and JaimovichE., “Differences in both inositol 1,4,5-trisphosphate mass and inositol 1,4,5-trisphosphate receptors between normal and dystrophic skeletal muscle cell lines”, Muscle Nerve21, 902 (1998).
13.
ChaurandP.SchwartzS.A.BillheimerD.BaogangJ.X.CrecelliusA. and CaprioliR.M., “Integrating histology and imaging mass spectrometry”, Anal. Chem.76, 1145 (2004).
14.
KarasM. and HillenkampF., “Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons”, Anal. Chem.60, 2299 (1988).
15.
BrunelleA.ChaurandP.Della-NegraS.Le BeyecY. and ParilisE., “Secondary electron emission yields from a CsI surface under impacts of large molecules at low velocities (5x103−7x104 ms−1)”, Rapid. Commun. Mass Spectrom.11, 353 (1997).
16.
LaugesenS. and RoepstorffP., “Combination of two matrices results in improved performance of MALDI MS for peptide mass mapping and protein analysis”, J. Am. Soc. Mass Spectrom.14, 992 (2003).
17.
HanX. and GrossR.W., “Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry,”J. Am. Soc. Mass Spectrom.6, 1202 (1995).
18.
HsuF.F. and TurkJ., “Electrospray ionization/tandem quadrupole mass spectrometric studies on phosphatidylcholines: The fragmentation processes”, J. Am. Soc. Mass Spectrom.14, 352 (2003).
19.
ColeM.J. and EnkeC.G., “Direct determination of phospholipid structures in microorganisms by fast atom bombardment triple quadrupole mass spectrometry”, Anal. Chem.63, 1032 (1991).
20.
PearceP.H.JohnsenR.D.WysockiS.J. and KakulasB.A., “Muscle lipids in Duchenne muscular dystrophy”, Aust. J. Exp. Biol. Med. Sci.59, 77 (1981).
21.
SantiniM.T.IndovinaP.L. and CantaforaA., “The cesium-induced delay in myoblast membrane fusion is accompanied by changes in cellular subfraction lipid composition”, Biochim. Biophys. Acta1070, 27 (1991).
22.
AndersonJ.E., “Myotube phospholipid synthesis and sarcolemmal ATPase activity in dystrophic (mdx) mouse muscle”, Biochem. Cell Biol.69, 835 (1991).
23.
OwensK. and HughesB.P., “Lipids of dystrophic and normal mouse muscle: Whole tissue and particulate fractions”, J. Lipid Res.11, 486 (1970).
24.
MurphyM.E. and KehrerJ.P., “Oxidative stress and muscular dystrophy”, Chem. Biol. Interact.69(2/3), 101 (1989).
25.
KunzeD.ReichmannG.EggerE.OlthoffD. and DohlerK., “Fatty acid pattern of lipids in normal and dystrophic human muscle”, Eur. J. Clin. Invest.5(6), 471 (1975).
26.
TouboulD.HalgandF.BrunelleA.KerstingR.TallarekE.HagenhoffB. and LaprévoteO., “Tissue molecular imaging by gold cluster ion bombardment”, Anal. Chem.76, 1550 (2004).
